iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Quintet Private Bank Europe S.A.

Quintet Private Bank Europe S.A. cut its position in iShares Biotechnology ETF (NASDAQ:IBB) by 32.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,936 shares of the financial services provider’s stock after selling 4,816 shares during the quarter. Quintet Private Bank Europe S.A.’s holdings in iShares Biotechnology ETF were worth $1,314,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $29,000. HHM Wealth Advisors LLC raised its position in iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the last quarter. Bradley & Co. Private Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the 4th quarter worth $32,000. Newbridge Financial Services Group Inc. acquired a new stake in iShares Biotechnology ETF during the 4th quarter worth $33,000. Finally, Hager Investment Management Services LLC purchased a new position in iShares Biotechnology ETF during the 4th quarter worth $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $137.03 on Monday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The stock has a market capitalization of $6.33 billion, a price-to-earnings ratio of 24.52 and a beta of 0.77. The company has a 50-day simple moving average of $135.91 and a 200-day simple moving average of $140.61.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.